Illumina Ventures is a life sciences VC fund with an emphasis on genomics and a partnership with Illumina. The $230M fund invests primarily in Series A tools, diagnostics, and therapeutics companies with a focus on early-stage, disruptive technologies and platforms. The investment team members have strong scientific and extensive entrepreneurial backgrounds and aim to add value for all of their portfolio companies.
On April 4th 2018, investment team members at Illumina Ventures, Wouter Meuleman and Noel Jee, will give an overview presentation about the venture capital firm’s key areas of interest. Following the presentation, you’ll have the opportunity to introduce yourself to Wouter and Noel during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Illumina Ventures provides an intimate forum to discuss your company.
Some areas of interest include:
- Genomics Research and Tools
- Therapeutics companies and discovery platforms (oncology, infectious disease, etc.)
- Reproductive Health
- Applied Genomics
- Complex Diseases
- Microbial Genomics and Microbiome
- Informatics and Genomics Analysis
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on March 21, 2018.
Illumina Ventures Participating Representatives:
Wouter Meuleman PhD | Director of Investments
Noel Jee PhD | Investment Associate